MEK-Inhibitor Associated Retinopathy (MEKAR)
- Targeted cancer therapies can cause ocular toxicity
- It is important to distinguish these ocular toxicities from other ocular conditions. For example: central serous chorioretinopathy (CSR)
- These cases can be observed without the need for intervention (and often continued on life-saving cancer treatment)